Overview
- Sam Neill, 78, said in an interview with Australia’s 7News that a recent scan found no detectable cancer after CAR-T treatment.
- He had been treated for a form of Non-Hodgkin lymphoma, and he said chemotherapy kept him alive before it stopped working.
- CAR-T therapy removes a patient’s immune cells, engineers them to attack cancer, and infuses them back, a labor‑intensive process used for some blood cancers.
- Neill is urging wider access to CAR-T in New Zealand, where reports say patients can currently get it only in clinical trials.
- Doctors in Heidelberg say the therapy can help some aggressive lymphomas and certain leukemias, yet in Germany it is approved for only a few types, and Neill now says he feels ready to make a film again.